An immunosuppressive and anti-inflammatory HLA class I-derived peptide binds vascular cell adhesion molecule-1

Transplantation

Volumn 70, Issue 4, 2000, Pages 662-667

  Ling, Xuefeng ^a   Tamaki, Tomoaki ^a   Xiao, Yun ^a   Kamangar, Salar ^a   Clayberger, Carol ^a   Lewis, David B ^a   Krensky, Alan M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN BINDING FACTOR; LIGAND; SYNTHETIC PEPTIDE; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HLA SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY;

EID: 0034721341     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200008270-00021     Document Type: Article

References (39)

1. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
2. Natural killer cell receptors and MHC class I interactions
3. HLA derived peptides as a novel strategy for the prevention of allograft rejection
4. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2
5. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes
6. Peptides corresponding to the CD8 binding region of HLA class I block the differentiation of cytotoxic T lymphocyte precursors
7. Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses
8. Peptides corresponding to the CD8 and CD4 binding domains of HLA molecules block T lymphocyte immune responses in vitro
9. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A
10. Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses
11. Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: Functional similarities but mechanistic differences with the immunosuppressive drug rapamycin
12. HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family
13. Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide
14. A novel genetic system to detect protein-protein interactions
15. A simple and highly efficient procedure for rescuing autonomous plasmids from yeast
16. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response
17. Recognition of an HLA public determinant (Bw4) by human allogeneic cytotoxic T lymphocytes
18. The induction of tolerance to alloantigens using HLA based synthetic peptides
19. Prolongation of skin allograft survival in mice following administration of ALLOTRAP
20. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a 75-84) from the alpha i helix of the first domain of HLA-B701
21. Leukocyte adhesion to endothelium in inflammation
22. Adhesion receptors of the immune system
23. Importance of endothelial VCAM-1 for inflammatory leukocytic infiltration in vivo
24. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue
25. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes
26. Circulating adhesion molecules in disease
27. VCAM-1/alpha 4-integrin adhesion pathway: Therapeutic target for allergic inflammatory disorders
28. Monoclonal antibodies to the integrin alpha 4 subunit inhibit the murine contact hypersensitivity response
29. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo
30. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways
31. Administration of monoclonal antibodies against vascular cell adhesion molecule/ very late antigen-4 abrogates predisposing autoimmune diabetes in NOD mice
32. Antibody to VLA-4, but not to L-selectin, protects neuronal M2 muscarinic receptors in antigen-challenged guinea pig airways
33. Vascular cell adhesion molecule-Ig fusion protein selectively targets activated alpha 4-integrin receptors in vivo: Inhibition of auto-immune diabetes in an adoptive transfer model in nonobese diabetic mice
34. The molecular structure of cell adhesion molecules
35. Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4
36. Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin
37. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: Costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1
38. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes
39. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers